Zynex Inc

ZYXI

$7.98

Closing

▲4.18%

1D

▼-26.72%

YTD

ZYXI

BBG001S7T7V0

Market cap

$253.31M

52 week high

$13.77

52 week low

$7.05

Volume

24,149

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$253.31M

Analysts' Rating

BUY

Price Target (Mean)

17.75

Total Analysts

3

P/E

46.02

Operating Margin

4.46%

Beta

0.54

Revenue Growth

10.97%

52 week high

$13.77

52 week low

$7.05

Div. Yield

%

EPS Growth

Infinity

Company Profile

Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.